SEC ownership of BioCardia, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000925741.

Comparable stake leader

Thomas A. Satterfield Jr.

Disclosed value leader

Lincoln Alternative Strategies LLC

Comparable rows

22/33

Latest evidence

29 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
22 of 33
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Thomas A. Satterfield Jr.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
29 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000925741
Issuer location
Sunnyvale, CA

Ownership snapshot

Top shareholders of BioCardia, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Thomas A. Satterfield Jr.
Disclosed value leader
Lincoln Alternative Strat...
Comparable rows
22/33
Latest evidence
29 Jul 2026
13D/G 3/4/5 13F Lead comparable stake: 9.9% 11 rows are not safely comparable across share classes. 13D/G row: Thomas A. Satterfield Jr. Showing 1-8 of 33 holder rows.

Quick read

Thomas A. Satterfield Jr. leads the comparable SEC ownership view at 9.9%.

22 of 33 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Thomas A. Satterfield Jr.'s linked filing trail.
Comparable ownership Top 5
Thomas A. Satterfield Jr. 9.9%
Lincoln Alternative Strategies LLC 7.5%
Blank Andrew Scott 5.5%
INTRACOASTAL CAPITAL, LLC 5%
CM Management, LLC 1.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 33 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Thomas A. Satterfield Jr.
13D/G
9.9%
$1,356,010
592,144 shares
+$467,153 30 Jun 2025
Lincoln Alternative Strategies LLC
13D/G
7.5%
$1,560,000
800,000 shares
$0 19 Sep 2025
Blank Andrew Scott
13D/G 3/4/5
Director
5.5%
$848,672
278,253 shares
$0 23 Apr 2025
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
$1,086,499
557,179 shares
$0 18 Sep 2025
CM Management, LLC
13F
Company
13F
1.2%
$157,300
130,000 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
1.1%
$150,755
124,591 shares
31 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.84%
$114,086
94,287 shares
31 Mar 2026
VANGUARD FIDUCIARY TRUST CO
13F
Company
13F
0.59%
$80,187
66,270 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$1,078,688.

Buys
$1,078,688
Insiders: 3
Sells
$0
Insiders: 0
Net
+$1,078,688
Shares: +901,200
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 901,200 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 151,700 0 $142,345 $0 +$142,345
3-6 6,900 0 $7,890 $0 +$7,890
6-9 7,000 0 $8,288 $0 +$8,288
9-12 735,600 0 $920,164 $0 +$920,164

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-12 of 12 reporting-owner rows connected to BioCardia, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
12
Largest Forms 3/4/5 holder
Et al Phillip Frost MD
Net 12M change
+$1,081,676
Latest report
29 Jul 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Et al Phillip Frost MD 10%+ Owner $815,291 Filing P/S 19 Jan 2024
Blank Andrew Scott Director $796,496 +$360,000 +82% Mixed 06 Jul 2026
Peter Altman President and CEO, Director $291,630 +$120,092 +70% Filing P/S 29 Jul 2026
Simon H. Stertzer Director $173,721 +$601,584 +346% Mixed 06 Jul 2026
David McClung Chief Financial Officer $138,236 Mixed 02 Jul 2026
Edward M. Gillis Senior Vice President, Devices $65,492 Mixed 02 Jul 2026
Richard M. Krasno Director $30,990 Filing P/S 23 Apr 2025
Bill Facteau Director $24,999 Filing P/S 06 Jul 2026
Jim L. Allen Director Mixed 06 Jul 2026
Krisztina M. Zsebo Director Mixed 10 Jun 2022
Marvin Slosman Director Mixed 06 Jul 2026
Jay M. Moyes Director Mixed 06 Jul 2026

Recent insider transactions for BioCardia, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Peter Altman BCDA Common Stock Purchase 1.36% $3,900 $0.7800 5,000 373,885 29 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.14% $415 $0.8300 500 368,885 17 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.41% $1,290 $0.8600 1,500 368,385 15 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.77% $2,464 $0.8800 2,800 366,885 14 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.27% $940 $0.9400 1,000 369,485 10 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.27% $900 $0.9000 1,000 368,485 09 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.52% $5,335 $0.9700 5,500 367,485 08 Jul 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.51% $5,208 $0.9645 5,400 361,985 08 Jul 2026 Direct
Simon H. Stertzer BCDA Stock Option (right to buy) Award 51.4% 8,000 23,573 06 Jul 2026 Direct
Marvin Slosman BCDA Stock Option (right to buy) Award 66.7% 8,000 20,000 06 Jul 2026 Direct
Peter Altman BCDA Stock Option (right to buy) Award 64% 57,688 147,903 06 Jul 2026 Direct
David McClung BCDA Stock Option (right to buy) Award 89.6% 41,501 87,841 06 Jul 2026 Direct
Edward M. Gillis BCDA Stock Option (right to buy) Award 92.9% 29,442 61,139 06 Jul 2026 Direct
Andrew Scott Blank BCDA Stock Option (right to buy) Award 52.2% 8,000 23,313 06 Jul 2026 Direct
Jim L. Allen BCDA Stock Option (right to buy) Award 52.2% 8,000 23,313 06 Jul 2026 Direct
Jay M. Moyes BCDA Stock Option (right to buy) Award 51.4% 8,000 23,573 06 Jul 2026 Direct
Bill Facteau BCDA Stock Option (right to buy) Award 50.9% 8,000 23,729 06 Jul 2026 Direct
Peter Altman BCDA Common Stock Tax liability -13.3% -54,606 356,585 02 Jul 2026 Direct
David McClung BCDA Common Stock Tax liability -16.8% -23,125 114,245 02 Jul 2026 Direct
Edward M. Gillis BCDA Common Stock Tax liability -24.2% -17,269 54,126 02 Jul 2026 Direct
Peter Altman BCDA Common Stock Award 36.8% 110,625 411,191 29 Jun 2026 Direct
David McClung BCDA Common Stock Award 78.7% 60,483 137,370 29 Jun 2026 Direct
Edward M. Gillis BCDA Common Stock Award 124% 39,521 71,395 29 Jun 2026 Direct
Simon H. Stertzer BCDA Common Stock Purchase 30.6% $39,000 $1.00 39,000 166,338 23 Jun 2026 Direct
Simon H. Stertzer BCDA Common Stock Purchase 122.9% $64,584 $0.9200 70,200 127,338 22 Jun 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.27% $768 $0.9600 800 300,566 18 Jun 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.5% $1,275 $0.8500 1,500 299,766 17 Jun 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.7% $4,250 $0.8500 5,000 298,266 09 Jun 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.51% $1,380 $0.9200 1,500 293,266 20 May 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.07% $190 $0.9500 200 291,766 19 May 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.99% $5,244 $0.9200 5,700 291,566 18 May 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.82% $5,202 $1.02 5,100 285,866 15 May 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.81% $5,550 $1.11 5,000 280,766 29 Apr 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.15% $492 $1.23 400 275,766 21 Apr 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.22% $738 $1.23 600 275,366 20 Apr 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.11% $366 $1.22 300 274,766 25 Mar 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.22% $744 $1.24 600 274,466 24 Mar 2026 Direct
Peter Altman BCDA Common Stock Purchase 1.86% $5,650 $1.13 5,000 273,866 04 Feb 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.11% $402 $1.34 300 268,866 21 Jan 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.22% $792 $1.32 600 268,566 20 Jan 2026 Direct
Peter Altman BCDA Common Stock Purchase 0.34% $1,170 $1.30 900 267,966 17 Dec 2025 Direct
Peter Altman BCDA Common Stock Purchase 0.07% $274 $1.37 200 267,066 16 Dec 2025 Direct
Bill Facteau BCDA Stock Option (right to buy) Award 321.8% 12,000 15,729 08 Dec 2025 Direct
Marvin Slosman BCDA Stock Option (right to buy) Award 12,000 12,000 08 Dec 2025 Direct
Andrew Scott Blank BCDA Stock Option (right to buy) Award 362.2% 12,000 15,313 08 Dec 2025 Direct
Jim L. Allen BCDA Stock Option (right to buy) Award 362.2% 12,000 15,313 08 Dec 2025 Direct
David McClung BCDA Common Stock Tax liability 61.7% 29,339 76,887 08 Dec 2025 Direct
David McClung BCDA Common Stock Award 121.5% 58,276 106,226 08 Dec 2025 Direct
David McClung BCDA Stock Option (right to buy) Award 139.6% 27,000 46,340 08 Dec 2025 Direct
Peter Altman BCDA Common Stock Tax liability 26.8% 56,484 266,866 08 Dec 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .